source
- Novo Nordisk acquires three early-stage obesity programs from KallyopeNovo Nordisk announced the purchase of three early-stage obesity drug programs from New York‑based biotech Kallyope, expanding its metabolic pipeline. The acquired assets are not GLP‑1 incretins.…
- Trump announces GENEROUS model, securing pharma deals to cut Medicaid drug pricesPresident Trump announced a new initiative called the GENEROUS model that is intended to lower drug prices for state Medicaid programs. The program will involve all 50 states, Washington, D.C., an…